1.
Emerg Infect Dis
; 30(6): 1289-1291, 2024 Jun.
Artículo
en Inglés
| MEDLINE
| ID: mdl-38669127
RESUMEN
Using the GISAID EpiCoV database, we identified 256 COVID-19 patients in Japan during March 31-December 31, 2023, who had mutations in the SARS-CoV-2 nonstructural protein 5 conferring ensitrelvir resistance. Ongoing genomic surveillance is required to monitor emergence of SARS-CoV-2 mutations that are resistant to anticoronaviral drugs.